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Psychometric validation of three new
condition-specific questionnaires to assess
quality of life, symptoms and treatment
satisfaction of patients with aortic
aneurysm
Jacquelyn Romaine1* , George Peach2, Matt Thompson3, Robert J. Hinchliffe4 and Clare Bradley1,5
Abstract
Background: To evaluate the psychometric properties of three new condition-specific questionnaires designed to
assess outcomes amongst patients under pre-operative surveillance for a small abdominal aortic aneurysm (AAA) or
who have undergone aneurysm repair. These tools are the Aneurysm-Dependent Quality of Life measure
(AneurysmDQoL), the Aneurysm Symptom Rating Questionnaire (AneurysmSRQ) and the Aneurysm Treatment
Satisfaction Questionnaire (AneurysmTSQ).
Results: The questionnaires were sent to 297 patients with abdominal aortic aneurysm (AAA) or who had
undergone AAA repair (using open or endovascular technique) sampled from five UK NHS Trusts. Exploratory Factor
Analysis was used to examine factor structure together with reliability analysis. A subset of 65 patients completed
the questionnaires a second time four months later. One hundred and ninety-seven patients (178 men; 18 women)
provided data for analysis (69% response rate): mean age was 75 years (range 60–95). Nineteen were under
pre-operative surveillance for AAA and 178 had undergone AAA repair (70 open repair; 104 endovascular repair; 4
uncertain). Exploratory Factor Analysis of the AneurysmDQoL and the AneurysmTSQ each demonstrated a
one-factor structure. The AneurysmSRQ demonstrated a six-factor structure (emotional, weight loss, lower limb,
cognitive, general malaise and gastrointestinal symptoms) and a one-factor composite symptom scale. All scales
have clean factor structures: item loadings above 0.40, no cross-loadings, and no factors with fewer than three
items. Internal consistency reliability was excellent (α = 0.869–0.959) and test-retest reliability good (Intraclass
correlation coefficient = 0.70–0.88).
Conclusions: The three new questionnaires have a clear structure and strong reliability and are now ready for use
in clinical trials and routine practice, which will allow evaluation of responsiveness to change.
Keywords: Abdominal aortic aneurysm, PROMs, Quality of life, Treatment satisfaction, Symptoms, Psychometric
development
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Introduction
An abdominal aortic aneurysm (AAA) is a localised dila-
tion of the lower part of the aorta which, if ruptured, is
likely to be fatal [1]. Abdominal aortic aneurysms be-
come more common with age and are more common in
men [2]. Over time AAAs tend to expand and as they
do so, the risk of rupture increases. Small AAAs (3-5
cm) are monitored using periodic ultrasound surveil-
lance and AAA repair is generally only recommended
once the aneurysm reaches 5.5 cm - the point where the
risk of rupture outweighs the risk associated with elect-
ive repair. In 2009, the phased implementation of a na-
tional screening program (National Abdominal Aortic
Aneurysm Screening Program NAAASP) began in the
UK [3]. The NAAASP currently invites all men for ultra-
sound AAA screening on reaching 65 years of age. Those
found to have an AAA are either enrolled into ongoing
surveillance or put forward for repair if already at
threshold size [4].
Techniques of AAA repair have evolved significantly in
recent years with large numbers now treated using endo-
vascular stent-grafts that allow minimally invasive repair.
As a result, surgical mortality has fallen dramatically [5]
and markers of surgical quality expanded to include pa-
tient reported outcomes (PROs), including symptoms,
treatment satisfaction and quality of life (QoL). The im-
pact of being made aware of the condition, the need for
ongoing surveillance and the need to take new medica-
tions (e.g. statins) each have the potential to impact on
QoL. Identifying strengths and deficiencies in care from
the patients’ perspective can help clinicians strive for even
higher quality care rather than simply avoiding morbidity
and mortality. The UK Department of Health has, over re-
cent years, undertaken a nationwide initiative to encour-
age the use of PRO measures (PROMs), both in the
surgical specialties in general and in aortic aneurysm sur-
gery specifically. However, until now, no validated
aneurysm-specific PROMs exist.
In the absence of a validated aneurysm-specific QoL
measure, all previous studies purporting to measure
QoL in patients with AAA have used generic tools such
as the Medical Outcomes Study Short-Form 36 (SF-36)
or the EuroQol-5D (EQ-5D) [6–8]. Although often pre-
sented as measures of QoL or ‘health-related quality of
life’ (HRQoL), these tools are actually measures of health
status (i.e. physical and mental function) rather than true
QoL. Quality of life is a much broader concept that in-
corporates (but is not limited to) how dysfunctional
physical and/or mental status and other demands of a
condition and its treatment may impact upon patients’
lives. To assess the impact of AAA and its treatment on
QoL, three new condition-specific questionnaires have
been developed using an iterative process of focus
groups and in-depth interviews involving patients with
AAA [9]. The newly designed questionnaires are: The
Aneurysm-Dependent Quality of Life Questionnaire
(AneurysmDQoL), the Aneurysm Symptom Rating
Questionnaire (AneurysmSRQ) and the Aneurysm
Treatment Satisfaction Questionnaire (AneurysmTSQ).
The AneurysmDQoL
The design of the AneurysmDQoL was based upon the
Audit of Diabetes-Dependent Quality of Life (ADDQoL) -
a widely used questionnaire designed for use by people with
diabetes [10, 11]. The ADDQoL has also been adapted for
use by people with many other conditions including renal
disease (RDQoL), macular disease (MacDQoL), growth
hormone deficiency (HDQoL), hypothyroidism (ThyDQoL)
and diabetic retinopathy (RetDQoL) [12–16]. Influenced by
the way QoL was conceptualized in the design of the SEI-
QoL (Schedule for the Evaluation of Individual Quality of
Life) interview methodology [17], the AneurysmDQoL rec-
ognizes individual differences in the experience of quality of
life. Unlike the majority of QoL and health status tools, re-
spondents indicate if an aspect of life (e.g. work) is not rele-
vant to them and, for those aspects that are of relevance,
they are asked to rate not only how much each aspect of
their life has been affected by their condition (impact), but
also how important they consider this aspect of their life to
be for their QoL (importance) (Fig. 1).
Part (a) of each item is scored from − 3 (greatest nega-
tive impact) to + 1 (positive impact) and part (b) is
scored from 3 to 0 (very important to not at all import-
ant). The ‘Weighted Impact’ (WI) of AAA on that par-
ticular aspect of life is then calculated by multiplying the
impact score by the importance score (scores range from
− 9 to + 3). In this way the AneurysmDQoL is sensitive
to the fact that any given aspect of life may have differ-
ent significance to different individuals and therefore is
likely to have varying impact on QoL, and that the im-
portance of a particular aspect of life may change over
time even for the same individual. An Average Weighted
Impact score (AWI), can be obtained by summing the
WI scores and dividing by the number of applicable do-
mains (scores range from − 9 to + 3). Thus, scoring ig-
nores non-applicable domains and gives greater
emphasis to domains of greater importance to the indi-
vidual, providing a highly personalised assessment of the
impact of AAA on an individual’s QoL.
The AneurysmDQoL includes 24 questions in total:
two initial overview items - current QoL and how QoL
would be different if respondents had not had an
aneurysm, and 22 domain-specific items (e.g. family,
household tasks) [9].
The AneurysmSRQ
The AneurysmSRQ is a measure of symptoms associated
with AAA and its treatment which assesses the degree to
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which patients are bothered by applicable symptoms. The
format of the questionnaire was developed in earlier work
with patients who had hypothyroidism [18] and has since
been adapted for other chronic conditions including
hypoglycaemia [19]. The AneurysmSRQ comprises 44
items, each divided into two parts. Part (a) asks respon-
dents to indicate if they have experienced the symptom in
recent weeks, regardless of the cause. Part (b) asks respon-
dents to indicate how much the symptom bothers them. If
the answer to part (a) is ‘No’, respondents are asked to go
straight to the next symptom. Applicable symptoms are
scored on a scale from 1 (not at all) to 4 (a lot).
The AneurysmTSQ
The Aneurysm Treatment Satisfaction Questionnaire
(AneurysmTSQ) is designed to measure treatment satisfac-
tion in people living with AAA. Based on the format of the
Diabetes Treatment Satisfaction Questionnaire [20] and
other -TSQ measures [21–23] the AneurysmTSQ explores
multiple aspects of treatment satisfaction (e.g. side-effects,
convenience). The AneurysmTSQ includes 11 Likert scale
items which are rated from 6 (very satisfied) to 0 (very dis-
satisfied). Items 1 to 7 are designed for patients undergoing
surveillance of small AAAs as well as those who have had
aneurysm repair (e.g. information, staff support). Items 8 to
11 are designed to assess post-operative aspects of the treat-
ment process (e.g. side-effects, follow-up) and are therefore
only suitable for patients following aneurysm repair. Items
can be used individually or they can be summed to give a
total treatment satisfaction score.
The present paper focuses on the psychometric valid-
ation of the new tools, involving examination of their
overall structure (including any subscales), internal
consistency and test-retest reliability. It reports optimal
scoring methods following use in clinical practice or
research.
Methods
Design
A cross-sectional survey design was used, with patients at
various points in the treatment pathway asked to complete
the three new questionnaires. At the time of data collection,
the national screening program had yet to be fully rolled out,
however in anticipation of this, all individuals diagnosed with
an AAA were invited to take part. The time-points chosen
for completion were: pre-operative intervention (surveillance
of AAAs < 5.5 cm) and 6weeks, 3months, 6months, 12
months and > 12months post-repair.
Participants
Questionnaires were completed by 297 patients diag-
nosed with AAA purposively sampled from five UK
NHS Trusts. Respondents included those under surveil-
lance for a small AAA and those who had undergone an
AAA repair. Target sample size was based on a partici-
pant to variable ratio of 4:1 (minimum 100). Previous re-
search using –DQoL and –TSQ measures for other
conditions have demonstrated strong reliabilities, high
factor loadings and a clean structure with such sample
sizes e.g. [22–24]. Data from 197 patients were available
for analysis (69% response rate).
The majority of participants were male. The mean age
for women was slightly higher than for men and a higher
number of men than women currently, or previously,
smoked: men = 72%, women = 45% (Table 1). The major-
ity of both men and women reported elective EVAR as
their AAA treatment (elective: men = 68%, women =
72%; EVAR: men = 51%, women = 78%). Mean time be-
tween operation and completing the questionnaire was
slightly higher for men than women (Table 2).
Ethnicity of participants was predominantly White
(men = 96%, women = 100%). A subset of patients
(n = 65) were asked to complete the questionnaire pack
Fig. 1 Example item from the AneurysmDQoL (numbers indicate score assigned to each rating)
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a second time (mean duration to retest = 4 months;
range 1–7months) to allow assessment of test-retest
reliability.
Procedure
Prior to the start of the study the UK National Research
Ethics Service (NRES Committee – London Chelsea −
11/LO/1416) approved the process of patient recruit-
ment and patients provided informed written consent at
each stage. Patients were recruited from five NHS
Healthcare Trusts: St George’s Healthcare NHS Trust,
North Bristol NHS Trust, Worcestershire Acute Hospi-
tals NHS Trust, Norfolk and Norwich University Hospi-
tals NHS Trust and University Hospital Southampton
NHS Foundation Trust. Other than St George’s Hospital
(chosen for the large numbers of EVAR aneurysm re-
pairs performed), these centres were purposefully se-
lected for this study as they carry out significant
numbers of both OR and EVAR procedures. In each
centre, members of the healthcare team contacted all pa-
tients who had undergone aneurysm repair within the
preceding 12months and invited them to participate in
the study. Southampton also invited patients who had
undergone aneurysm repair between 12 and 24months
prior to the study. Two centres identified a number of
patients enrolled in preoperative surveillance of small
AAAs. Patients who expressed interest were then sent
the questionnaire pack (stamped addressed envelope in-
cluded for return). The pack included an information
sheet, consent form, detailed instructions and the
questionnaires.
Analytic approach
Prior to conducting the analyses, the data were screened
and relevant assumptions assessed. The correlation
matrix was inspected for poorly correlated items (r < 0.3)
and MSA (Measure of Sampling Adequacy) coefficients
for each variable checked (< 0.6 problematic). The
Kaiser-Meyer-Olkin value was checked to ensure it
exceeded the recommended value of 0.6 [25, 26] and
Bartlett’s Test of Sphericity [27] examined for statistical
significance.
Exploratory Factor Analysis (EFA) was conducted in
two stages. Initial analyses were carried out using a prin-
cipal components analysis (PCA: data reduction retain-
ing as much information as possible). Components were
considered for retention using three decision rules: Kai-
ser’s criterion (eigenvalues > 1), inspection of the Scree
plot and Horn’s parallel analysis [28]. Once the compo-
nents had been identified, a fixed factor EFA was run
(examining data structure and underlying construct(s)
using shared variance). All initial analyses were run
using an oblique (Direct Oblimin) rotation, to allow for
potential inter-correlations between components. Fac-
tors were considered to be related if they had a correl-
ation coefficient > 0.32. Due to the non-normal
distribution of the data, Principal Axis Factoring (PAF)
was the chosen method of extraction [29, 30]. Examin-
ation of the factor loadings focused on identifying the
‘cleanest’ factor structure (item loadings above 0.40 [31],
no or few item cross-loadings [> 0.32], and no factors
with fewer than three items) [27]. Factor loading
strength was guided by: fair (0.45), good (0.55), very
good (0.63), excellent (0.71) [32]. Poorly performing
items were dropped from the analysis one at a time and
the analysis rerun. All analyses used listwise deletion of
cases.
Internal consistency reliability analysis was run to de-
termine how many missing responses can be tolerated
when calculating a total scale score [33]. The strongest
contributing scale item was dropped and the analysis re-
run until alpha < 0.7 or 50% of items had been dropped.
Table 1 Participant gender, age and smoking status
Sex Age Smoker
N Mean SD Min Max N Missing Yes No Ex-smoker N Missing
Male 178 74.78 7.74 60 94 154 24 17 50 111 177 0
Female 18 77.24 9.17 64 95 12 6 3 10 5 18 0
Total 196 74.96 7.85 60 95 166 30 60 20 116 195 0
Table 2 Descriptive statistics by gender for treatment course, operation type and time since operation
Treatment Course Operation Type Time Since Operation (Months)
Sex Pre-Op Elective Rupture N Missing Open EVAR N Missing Mean SD N Missing
Male 16 121 10 178 31 68 90 158 20 12.13 6.78 126 52
Female 2 13 0 18 3 2 14 16 2 10.08 5.51 12 6
Total 18 132 10 196 34 70 104 174 22 11.96 6.69 138 58
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Intraclass correlation coefficients (ICC) were used to as-
sess test-retest reliability (two-way random, single, abso-
lute). Intraclass correlation coefficients were guided by:
excellent (≥ 0.81), good (0.61–0.80), moderate (0.41–
0.60), poor (≤ 0.40).
Results
Exploratory factor analysis of the AneurysmDQoL
A complete set of responses from 157 participants
(16 under surveillance; 141 post-repair) were included
in the analysis of the AneurysmDQoL. Examination of
data suitability led to the removal of Item 2: work.
Reasons for this included an MSA value of 0.349 and
160 out of 197 participants reporting work as
non-applicable).
Principal components analysis suggested a one-factor
solution. The forced one-factor EFA found that the 22
items in the AneurysmDQoL accounted for 51.99% of
the total variance within the data. Analysis of the factor
matrix however revealed Item 15 (finance) loaded at
0.350. After removal of Item 15 (finance) the lowest
loading item was Item 23 (value each day). The relatively
weak loading (0.472) combined with problems
highlighted during the design phase (meaning unclear)
led to the removal of Item 23. The rerun forced
one-factor 20-item EFA now explained 55.54% of the
variance in the data. All items now loaded > 0.5. Cron-
bach’s-α coefficient of internal consistency was very high
and test-retest reliability was good. Internal consistency
reliability run to determine how many missing responses
can be tolerated when calculating a total scale score re-
vealed that the AneurysmDQoL remains reliable (α >
0.85) even if patients omit responses for up to eight core
items (items with no non-applicable option). Table 3
demonstrates factor loadings, communalities and reli-
ability coefficients.
To ensure the tool would be suitable for use by pre-
and post-repair patients, analyses were rerun with
post-repair patients only (n = 141). A 20-item
single-factor solution again revealed the cleanest struc-
ture, explaining 55.38% of the variance. All items loaded
> 0.48 and Cronbach’s-α coefficient of internal
consistency was again high (0.959) and test-retest reli-
ability good (0.66). The results of these analyses support
the use of a single-scale, 20-item AneurysmDQoL as a
measure of the impact of AAA on quality of life for pa-
tients under surveillance for a small AAA and for pa-
tients following AAA repair.
Table 3 AneurysmDQoL - Factor loadings, communalities and reliability coefficients (pre and post-repair patients), ordered by factor loadings
Quality of life domain Factor 1 Communalities Alpha if item deleted (Original alpha = 0.959)
Household tasks 0.865 0.748 0.956
Family life 0.864 0.746 0.956
Friendships 0.837 0.701 0.956
Holiday 0.836 0.698 0.956
Getting out & about 0.831 0.691 0.956
Energy 0.829 0.687 0.956
Physical 0.819 0.671 0.956
Leisure 0.796 0.634 0.957
Do things for others 0.792 0.628 0.957
Health 0.791 0.626 0.957
Feelings about the future 0.774 0.599 0.957
Long journeys 0.768 0.590 0.957
Physical discomfort 0.747 0.557 0.957
Anxiety 0.688 0.473 0.958
Depend on others 0.687 0.471 0.958
Personal relationship 0.659 0.434 0.958
Others worry about me 0.583 0.340 0.959
Think clearly 0.546 0.299 0.960
Enjoy food 0.510 0.230 0.960
Sex life 0.506 0.256 0.960
Percentage total
variance = 55.54
Number of items
in scale = 20
Alpha = 0.959 ICC = 0.70
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Exploratory factor analysis of the AneurysmSRQ
Responses from 164 participants were included. Low
MSA values led to the removal of three items (pain in but-
tocks 0.478, wound infection 0.572, difficulty urinating
0.568). Principal components analysis of the remaining 41
items (n = 166) revealed a six-component solution. A
forced-six factor EFA (oblique rotation) explained 42.38%
of the total variance within the data. Examination of the
factor loadings led to the stepwise removal of 17 items.
The 24-item six-factor solution accounted for 52.62%
of the variance within the data and all items loaded >
0.43. All factors demonstrated good internal consistency
and moderate to excellent test-retest reliability. Details
of factor names, factor loadings, communalities, and re-
liability coefficients are presented in Table 4.
To assess the importance of each item and clarify
whether items not included in the six subscales should be
removed from the questionnaire, the frequency and bother
ratings of each item were examined (Table 5 and 6). This
process demonstrated that while similar patterns of re-
sponse were not found among these items (therefore not
included in the subscales), many patients experienced these
symptoms and/or described them as causing moderate or
severe bother. It was therefore decided that these items
would remain in the questionnaire as stand-alone items.
Frequency responses also demonstrate no floor or ceiling
effects (> 15% having highest / lowest score) [34].
Though six clear subscales had been identified within
the AneurysmSRQ, the potential pragmatic benefits of
having a single summable symptom scale were also
recognised. In order to identify the maximum number of
items that could be combined into a single scale a forced
one-factor EFA was run. Examination of the factor load-
ings led to the removal of 17 low-loading items. The
final one-factor solution comprised 24 items. All items
loaded > 0.4, and explained 30.15% of variance in the
data. This factor was titled the ‘Composite Symptom
Scale’ and provides the broadest single overall score for
bother from symptoms. Internal consistency reliability
was very high and ICC excellent.
Internal consistency reliability analysis run to deter-
mine how many missing responses can be tolerated
when calculating the AneurysmSRQ Composite Symp-
tom Scale revealed that the scale remains reliable
even if patients omit responses for up to 12 items.
Table 7 demonstrates factor loadings, communalities
and reliability coefficients.
Exploratory factor analysis of the AneurysmTSQ
The AneurysmTSQ includes 11 items, all of which are
suitable for patients who have undergone AAA repair.
Items one to seven are also suitable for patients under-
going AAA pre-repair surveillance.
Post-repair patients
Treatment satisfaction data were obtained from 154
post-repair patients. Data suitability checks all proved sat-
isfactory. A PCA of the 11 AneurysmTSQ items suggested
a one component solution. The forced-one-factor EFA ex-
plained a total of 49.69% of the total variance within the
data. Examination of the factor loadings revealed all items
loaded > 0.476. Cronbach’s alpha was strong and ICC
demonstrated excellent test-retest reliability. Details of the
factor loadings, communalities and reliability coefficients
are presented in Table 8. These results support the use of
the 11-item AneurysmTSQ as a measure of total treat-
ment satisfaction for patients who have received
post-operative care for an aortic aneurysm.
Pre and post-repair patients
Treatment satisfaction data were obtained from 182 par-
ticipants. Consistent with the 11-item EFA, PCA using
items 1–7 revealed a one-factor solution. The
seven-item one-factor solution accounted for 52.83% of
the variance within the data. Cronbach’s alpha coefficient
was strong and test retest reliability was good. Factor
loadings, communalities and reliability coefficients are
demonstrated in Table 9.
These results demonstrate support for a separate
7-item subscale suitable for use by patients pre-repair
surveillance in addition to the full 11-item measure of
treatment satisfaction for patients who have received
post-operative care for AAA.
Discussion
The psychometric analyses presented here provide de-
tailed information on the structure of the AneurysmD-
QoL, AneurysmSRQ and AneurysmTSQ and strongly
support their validity for use by patients with AAA.
The content validity of the three new tools was estab-
lished through an iterative design process involving pa-
tients at every stage to ensure all included items were
relevant to this patient group and no potentially import-
ant items were missing [9]. Strong evidence of the con-
struct validity of each tool has been demonstrated here
through psychometric analysis. All three tools have a
clear structure, strong internal consistency and good
test-retest reliability.
During the validation process, the value of single fac-
tor solutions was recognised as they have pragmatic ad-
vantages for clinical use. The data supported single
factor solutions for both the AneurysmDQoL and the
AneurysmTSQ. Analysis of the AneurysmDQoL con-
firmed that 20 of the initial 23 items could be combined
into a single scale with the item ‘value each day’ requir-
ing removal and the work and finance items being
retained in the questionnaire but not included in the
scale. It is perhaps not surprising that these particular
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items stood apart, since the majority of patients
undergoing AAA repair have retired from work.
Nonetheless, for those who are still in employment,
the impact on work and finances could potentially be
profound and the decision was therefore taken to re-
tain these two items in the questionnaire as
stand-alone items. In the UK, AAA medical care is
provided free at the point of use. In countries where
this is not the case, finances may be more impacted
by AAA. Given that finance loaded only marginally
lower than the 0.4 cut off and made a negligible dif-
ference to the internal consistency of the scale this
item could, if needed, be included in computing AWI
in countries where medical care is not provided free
of charge or in multinational clinical trials where fi-
nances may be more relevant in some countries.
The poor performance of the ‘value each day’ item was
not unexpected as several patients had found the item
difficult to understand during pilot testing. This item
was therefore completely removed from the question-
naire, resulting in the final 22-item version of the Aneur-
ysmDQoL with 20 items contributing to the scale score.
No changes were made to the AneurysmTSQ following
psychometric analysis. All items loaded onto a single factor
with good reliability. The data also suggest that the first
seven items can be used as a separate subscale for patients
who are currently under surveillance following diagnosis of a
small AAA but have not undergone repair. Due to the small
numbers of patients in the dataset currently under surveil-
lance, analysis of this subscale was conducted using data
from both pre and post-repair individuals who had under-
gone surveillance. Although the patient-centred design of the
Table 4 AneurysmSRQ Forced six-factor EFA - factor loadings, communalities and reliability coefficients
Symptom Factor 1:
Emotion
Factor 2:
Appetite
Factor 3:
Lower Limb
Factor 4:
Cognitive
Factor 5:
Malaise
Factor 6:
Gastro
Communalities Subscale alpha
if item deleted
Emotional 0.817 0.167 0.025 −0.032 0.011 − 0.076 0.675 0.834
Panic 0.746 −0.183 −0.103 − 0.100 0.024 0.132 0.586 0.865
Angry 0.724 −0.055 0.140 0.076 0.005 0.040 0.667 0.847
Depressed 0.668 0.148 0.027 0.084 0.051 0.160 0.689 0.850
Worried 0.663 0.070 0.069 0.183 0.012 −0.049 0.570 0.851
Lost weight −0.096 0.783 0.069 0.013 0.113 0.081 0.696 0.630
Poor appetite 0.150 0.650 0.010 0.000 −0.009 0.023 0.466 0.536
Nausea vomited 0.017 0.487 −0.025 −0.070 0.299 0.140 0.463 0.715
Pain in calves −0.048 0.078 0.731 0.009 −0.014 0.026 0.535 0.709
Tingling legs/feet 0.005 0.182 0.716 −0.022 −0.107 0.062 0.537 0.712
Heaviness in legs 0.074 −0.159 0.639 0.045 0.081 0.121 0.578 0.679
Weakness in legs 0.025 −0.020 0.445 0.193 0.189 −0.006 0.377 0.735
Swollen legs 0.145 −0.223 0.433 −0.035 0.153 −0.008 0.322 0.751
Memory problems −0.051 −0.085 − 0.130 0.896 0.034 0.075 0.777 0.726
Difficulty thinking 0.035 0.105 0.126 0.820 −0.070 −0.090 0.721 0.760
Difficulty concentrating 0.314 −0.058 0.130 0.518 −0.012 0.117 0.610 0.836
Minor Illnesses −0.029 0.018 0.105 −0.052 0.713 −0.057 0.515 0.580
Diarrhoea −0.045 0.012 −0.033 0.005 0.633 0.079 0.417 0.612
Feverish 0.090 0.174 −0.029 −0.035 0.562 −0.062 0.394 0.628
Headaches 0.094 −0.082 0.038 0.130 0.456 0.131 0.356 0.659
Bloated −0.066 −0.021 0.178 −0.024 − 0.082 0.637 0.429 0.653
Abdominal pain 0.205 0.090 −0.056 0.111 0.060 0.550 0.517 0.650
Flatulence −0.043 0.027 0.012 0.142 0.158 0.549 0.431 0.672
Indigestion 0.091 0.067 −0.034 −0.067 0.003 0.512 0.301 0.692
Percentage total variance 24.99 8.89 6.56 4.87 3.93 3.46
Items in scale 5 3 5 3 4 4
Alpha 0.88 0.72 0.76 0.84 0.69 0.73
ICC 0.69 0.47 0.69 0.82 0.59 0.80
Strongest factor loadings in bold
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measure provides strong content validity [9] and the free text
box provided with each questionnaire (allowing respondents
to report for example, any aspects of treatment satisfaction
not covered in the questionnaire) suggested no further addi-
tions were needed, further work with a larger pre-repair sur-
veillance dataset is required for confirmation of the
psychometric properties of the questionnaire when used only
with patients undergoing surveillance for small aneurysm.
In contrast to the other tools, analyses demonstrated
that the 44 items in the AneurysmSRQ could not be
combined into a single scale that included all items.
However, stepwise removal of items not contributing to
a single scale demonstrated that it was possible to com-
bine a total of 24 items into a single ‘Composite Symp-
tom Score’. Though this may not be a truly
comprehensive score, it does provide the broadest pos-
sible single indicator of symptom burden for these pa-
tients. Psychometric analysis also showed that six
subscales could be identified with the AneurysmSRQ:
emotion; appetite; lower-limb symptoms; cognitive func-
tion; general malaise; and gastrointestinal symptoms.
These subscales comprised a total of 24 items (not iden-
tical to composite symptom score items). Importantly,
although 20 items had to be excluded from the subscales
on the basis of the psychometric analysis, data from
focus groups and patient interviews had suggested that a
number of these excluded items were important to pa-
tients. Indeed, some items may have failed to load onto
subscales not because they are irrelevant or anomalous,
but because they are more general in nature. For ex-
ample, tiredness and back pain were each experienced
by more than 40% of respondents (Table 6). Further-
more, some of the non-scale items with very low fre-
quencies and bother ratings (e.g. wound infection;
bruising) are most likely to be experienced by patients in
the early post-repair group – a group relatively
under-represented in this study. The decision was there-
fore taken to retain all non-scale items in the question-
naire until further data are gathered to justify more fully
their retention or exclusion.
In addition to consistency and reliability, the criterion
validity of new questionnaires can also be evaluated.
Table 5 AneurysmSRQ frequency scores and bother ratings for all items included in the six subscales, ordered by item number
Symptom Mean SD No experience
of symptom
Bother Rating Total
N
Bothered by
symptom %Not at all A Little Moderate A lot
Headaches 2.54 0.79 167 2 12 11 3 195 14
Feverish 2.58 1.00 180 2 3 5 2 192 6
Pain/discomfort in calves 2.66 0.77 125 1 34 24 12 196 36
Abdominal pain 2.76 0.79 155 0 17 13 8 193 20
Minor Illnesses 2.38 0.95 143 10 19 16 7 195 27
Depressed or low 2.75 0.81 141 1 22 19 11 194 27
Feelings of panic 3.00 0.52 175 0 2 12 2 191 8
Worried/nervous 2.57 0.69 147 1 22 19 4 193 24
Irritable/angry 2.76 0.64 156 0 13 20 4 193 19
Emotional/upset 2.74 0.73 152 1 15 20 6 194 22
Difficulty concentrating 2.68 0.76 146 1 20 19 7 193 24
Memory problems 2.45 0.80 128 5 36 20 8 197 35
Difficulty thinking 2.42 0.71 140 3 30 18 4 195 28
Tingling legs/feet 2.54 0.70 127 1 37 24 7 196 35
Heaviness in legs 2.57 0.79 141 1 30 14 9 195 28
Weakness in legs 2.77 0.70 128 0 25 31 10 194 34
Swollen legs 2.48 0.75 168 2 12 11 2 195 14
Poor appetite 2.59 1.10 174 4 7 5 6 196 11
Lost weight 2.19 1.05 159 11 14 6 6 196 19
Indigestion or heartburn 2.41 0.79 147 4 26 14 5 196 25
Nausea/vomited 2.71 0.85 179 1 6 7 3 196 9
Flatulence or belching 2.63 0.88 124 5 31 22 14 196 37
Bloated 2.68 0.75 165 1 12 14 4 196 16
Diarrhoea 2.75 0.70 168 0 11 13 4 196 14
Mean scores exclude participants not experiencing a particular symptom
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Criterion validity is an assessment of the performance of
a new tool relative to a known ‘gold-standard’ measure.
In developing new QoL measures, however, this can be
problematic since there is often no existing gold stand-
ard. This is the case for patients with AAA. The system-
atic literature review performed prior to questionnaire
development demonstrated that almost all previous at-
tempts to describe QoL amongst patients with AAA
have actually used health status measures (such as the
SF-36 and EQ-5D) and have yielded an array of conflict-
ing results [7]. The disagreement in previous results sug-
gested that those tools may not have been suitable for
purpose and prompted the development of the new
questionnaires. It therefore follows that those tools
cannot be used as the standard against which the new
questionnaires are measured. Though comparison to a
‘gold standard’ was not possible, the need for such external
validation was minimised by the fact that the format of
the –DQoL, −TSQ and –SRQ measures have been tried
and tested for many other patient groups and many of the
items in the new questionnaires were derived from item li-
braries created in the course of designing and developing
the measures for other patient population tools [12, 13,
18–20, 22, 24, 35–40].
The data collected in this study were sufficient for
overall psychometric analysis (based on participant num-
ber, clean structure and number of high loading items)
and indicate that the new tools are valid for both
pre-repair surveillance and post-repair patients. None-
theless, a larger dataset that included a greater number
of pre-repair surveillance patients would have allowed
for direct confirmation of the psychometric properties
for pre-repair patients as a separate group. It is also
noted that the male: female distribution in our study
population was 9:1 whilst national data on the preva-
lence of the condition shows the male female ratio to be
6:1 [41]. It is unclear whether this ratio is truly represen-
tative of patients undergoing aneurysm repair or
whether women were less often invited or less inclined
to take part in the study. However, a similar or greater
proportion of women patients was also observed in
some of the largest studies of AAA repair to date, in-
cluding the EVAR-1 (9%), EVAR-2 (15%) and UKSAT
(18%) trials [42–44]. In addition, whilst the initial
intention had been to include a longitudinal cohort of
patients, this was ultimately not possible and for
logistical reasons we conducted a cross-sectional study
of patients at different stages pre- and post-aneurysm
Table 6 AneurysmSRQ frequency scores and bother ratings for all stand-alone items ordered by item number
Symptom Mean SD No experience
of symptom
Bother Rating Total
N
Bothered by
symptom %Not at all A Little Moderate A Lot
Tired 2.76 0.78 103 4 29 43 15 194 47
Pain/discomfort thighs 2.62 0.80 142 2 24 18 8 194 27
Pain/discomfort groin 2.71 0.80 159 0 19 11 8 197 19
Pain/discomfort buttocks 2.85 0.77 170 0 10 11 6 197 14
Pain/discomfort back 2.86 0.79 113 1 30 33 20 197 43
Wound Infection 2.56 1.01 186 1 4 2 2 195 5
Excessive bruising 2.30 0.87 174 4 7 8 1 194 10
Unsteady/uncoordinated 2.71 0.84 135 2 27 20 13 197 31
Dizzy/lightheaded 2.52 0.82 152 1 27 8 8 196 22
Trembling e.g. limbs 2.47 0.64 180 0 9 5 1 195 8
Lost interest in sex 2.60 0.96 145 7 14 18 9 193 25
Avoid sexual activity 2.67 0.77 178 1 6 9 2 196 9
Problems sexual function 2.83 0.95 136 6 14 23 16 195 30
Excessive sweating 2.72 0.94 170 2 9 8 6 195 13
Episodes too hot/cold 2.64 0.78 135 4 21 29 7 196 31
Sleep problems 2.84 0.81 134 3 17 29 13 196 32
Generally weak 2.67 0.81 136 3 22 27 8 196 31
Gained weight 2.03 0.77 158 9 18 8 1 194 19
Constipation 2.66 0.94 152 4 15 13 9 193 21
Difficulty urinating 2.44 0.71 167 1 14 8 2 192 13
Mean scores exclude participants not experiencing a particular symptom
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repair. Thus we have been able to examine subgroup
differences [45] but have yet to assess the tools’ respon-
siveness to change. This will need to be examined in
future research.
Conclusions
The increasing number of patients now attending
screening and undergoing EVAR repair, with its associ-
ated follow-up and increased risk of further intervention,
suggests an urgent need for condition-specific AAA
PROs measures. The AneurysmDQoL, AneurysmSRQ
Table 7 AneurysmSRQ composite symptom score - factor
loadings, communalities and reliability coefficients, ordered by
factor loading
Symptom Factor
Loading
Communalities Alpha if item deleted
(Overall alpha = 0.906)
Depressed or low 0.764 0.583 0.898
Generally weak 0.727 0.528 0.898
Tired or lethargic 0.702 0.493 0.898
Irritable or angry 0.683 0.466 0.900
Difficulty
concentrating
0.670 0.449 0.899
Worried or
nervous
0.647 0.419 0.901
Emotional or
upset
0.602 0.363 0.901
Abdominal pain 0.577 0.333 0.902
Episodes too
hot or cold
0.539 0.290 0.902
Feelings of
panic
0.535 0.286 0.903
Pain or
discomfort
in back
0.520 0.270 0.903
Weakness in legs 0.518 0.268 0.902
Trembling
e.g. limbs
0.516 0.266 0.904
Pain or
discomfort
in groin
0.482 0.233 0.903
Unsteady or
uncoordinated
0.475 0.225 0.903
Headaches 0.467 0.218 0.903
Heaviness
in legs
0.460 0.212 0.903
Excessive
sweating
0.459 0.211 0.904
Flatulence
or belching
0.454 0.207 0.904
Memory
problems
0.439 0.193 0.904
Difficulty
thinking
0.439 0.192 0.904
Dizzy or
lightheaded
0.435 0.190 0.904
Avoided
sexual
activity
0.422 0.178 0.905
Feverish 0.403 0.163 0.905
Percentage total
variance = 30.15
Number of items
in scale = 24
ICC = 0.81
Table 8 AneurysmTSQ factor loadings, communalities and
reliability coefficients: Post-repair patients
Aspect of
Treatment
Factor
Loading
Communalities Alpha if Item Deleted
(Overall alpha = 0.902)
Treatment 0.843 0.711 0.886
Information 0.831 0.690 0.892
Post-op
follow-up
0.829 0.687 0.884
Support staff 0.826 0.683 0.886
Convenience 0.724 0.525 0.891
Understand
treatment
0.713 0.509 0.892
Stay length 0.666 0.443 0.893
Results
feedback
0.631 0.398 0.898
Encourage
others
0.571 0.326 0.898
Discomfort
or pain
0.518 0.268 0.901
Side-effects 0.476 0.227 0.906
Percentage total
variance = 49.69
Number of items
in scale = 11
ICC = 0.88
Table 9 AneurysmTSQ factor loadings, communalities and
reliability coefficients: Pre and post-repair patients
Aspect of
Treatment
Factor
Loading
Communalities Alpha if Item Deleted
(Overall alpha = 0.869)
Support staff 0.830 0.689 0.833
Treatment 0.826 0.682 0.839
Information 0.793 0.628 0.838
Understand
treatment
0.771 0.594 0.841
Convenience 0.678 0.459 0.853
Results
feedback
0.678 0.459 0.858
Discomfort or
pain
0.432 0.186 0.888
Percentage total
variance = 52.83
Number of items
in scale = 7
ICC = 0.78
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and AneurysmTSQ are three new condition-specific
questionnaires that will allow clinicians to assess quality
of life, impact of symptoms and treatment satisfaction of
patients with AAA before or after repair. We have pub-
lished elsewhere evidence of their acceptability to pa-
tients [9] and evidence of between group differences
[45] and here reported clear structure, good internal
consistency, and test-retest reliability. Responsiveness to
change now needs to be assessed.
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